Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage.
about
Novel pharmacotherapies in diabetic retinopathySafety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization.Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit.Animal models of diabetic retinopathy: summary and comparison.Sulfonamides: a patent review (2008 - 2012).Drugs in Phase II clinical trials for the treatment of age-related macular degeneration.Anti-angiogenic Therapy for Retinal Disease.Current advances in the treatment of neovascular age-related macular degeneration.
P2860
Q27002622-19F11F28-2566-4015-808C-F1D7D3EC87ADQ36571709-2B7BCCBA-E4F9-4B84-9122-346A2175945FQ36573796-67D4D4C0-AAA2-49A2-B127-63B91AD62EE3Q37304677-2C746B6F-1C00-4C57-B41C-4039F30B665FQ38018632-92A7D924-4953-4114-80FF-93F02FE0A0AEQ38253067-86E65A55-DCF9-4E40-984D-B0D8F1D36AC4Q38805247-0CA9F3E6-4738-45B4-B0A3-C1A3E2C61D74Q38902191-3238B828-C56B-4F6C-BB5D-47C9D2EC5A8C
P2860
Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pazopanib, a multitargeted tyr ...... cular leukostasis and leakage.
@ast
Pazopanib, a multitargeted tyr ...... cular leukostasis and leakage.
@en
type
label
Pazopanib, a multitargeted tyr ...... cular leukostasis and leakage.
@ast
Pazopanib, a multitargeted tyr ...... cular leukostasis and leakage.
@en
prefLabel
Pazopanib, a multitargeted tyr ...... cular leukostasis and leakage.
@ast
Pazopanib, a multitargeted tyr ...... cular leukostasis and leakage.
@en
P2093
P2860
P1476
Pazopanib, a multitargeted tyr ...... cular leukostasis and leakage.
@en
P2093
Ashish Thakur
Robert I Scheinman
Uday B Kompella
Vidhya R Rao
P2860
P304
P356
10.1016/J.MVR.2011.09.001
P577
2011-09-16T00:00:00Z